This was among a series of decisions taken during a meeting chaired by Union Health Minister J P Nadda and Delhi Health Minister Satyendra Jain to review the preparedness in the national capital to address and manage swine flu in winter months.
Nadda assured support to Delhi government in its efforts to tackle the disease and emphasised that it was a joint effort between the Centre and Delhi government to ensure adequate measures are undertaken for timely and adequate action to minimise morbidity and mortality due to influenza A H1N1.
"Hospitals of both the central and Delhi government are to ensure adequate stock of drug Oseltamivir and other consumables and Delhi government would work out a mechanism to fix ceiling rate in a realistic manner for testing of influenza A H1N1 samples to minimise out-of-pocket expenditure by the general public," an official statement said.
Earlier, Nadda after chairing the meeting, tweeted,"Asked Delhi Health Minister @SatyendarJain to ensure no overcharging for Swine Flu tests by pvt labs."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
